
17.71 Delayed Data As of 4:00pm ET | ![]() Today’s Change | 12.43 Today|||52-Week Range 20.00 | -2.69% Year-to-Date |
Amicus' (FOLD) Q4 Earnings Miss Estimates, Sales Beat on Galafold Mar 02 / Zacks.com - Paid Partner Content | The Top New Buys of Larry Robbins' Firm Feb 26 / GuruFocus News - Paid Partner Content |
Denali's (DNLI) Q4 Earnings & Revenues Beat on Biogen Deal Mar 01 / Zacks.com - Paid Partner Content | Are Investors Undervaluing Takeda Pharmaceutical Co. (TAK) Right Now? Feb 19 / Zacks.com - Paid Partner Content |
Previous close | 17.24 |
Today’s open | 17.67 |
Day’s range | 17.53 - 17.79 |
Volume | 5,169,356 |
Average volume (3 months) | 2,869,777 |
Market cap | $52.3B |
Earnings growth (last year) | -74.46% |
Earnings growth (this year) | +341.99% |
Earnings growth (next 5 years) | +16.80% |
Revenue growth (last year) | +60.06% |
P/E ratio | 33.0 |
Price/Sales | 1.57 |
Price/Book | 1.19 |
Today’s change | Today’s % change | |
---|---|---|
VRTXVertex Pharmaceutica... | -3.46 | -1.63% |
---- | ||
REGNRegeneron Pharmaceut... | -8.25 | -1.81% |
---- |
Next reporting date | May 11, 2021 |
EPS forecast (this quarter) | $0.33 |
Annual revenue (last year) | $30.3B |
Annual profit (last year) | $406.9M |
Net profit margin | 1.34% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Osaka, Osaka |